Equitec Proprietary Markets, LLC Blueprint Medicines Corp Put Options Transaction History
Equitec Proprietary Markets, LLC
- $102 Million
- Q2 2025
Put Options
1 transactions
Others Institutions Holding BPMC
# of Institutions
46Shares Held
8.67MCall Options Held
8Put Options Held
151K-
Black Rock Inc. New York, NY6.65MShares$861 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8724KShares$93.7 Million0.05% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL419KShares$54.3 Million0.01% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL155KShares$20 Million0.09% of portfolio
-
Ghost Tree Capital, LLC New York, NY140KShares$18.1 Million4.85% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...